Skip to content
TrialScanner

NCT01189396

Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006

Phase 2CompletedAMPHLead

Registry record

Lead sponsor
Amphastar Pharmaceuticals, Inc.
Conditions
Asthma; Bronchospasm; Chronic Obstructive Pulmonary Disease (COPD)
Primary completion
Dec 2010Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01189396 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01189396: Escalating and Cumulative-Dos... | TrialScanner